REMS: Added Expense For Pharma, Added Opportunity For Suppliers
Executive Summary
The first anniversary of REMS is March 25: one year from the effective date of the FDA Amendments Act provisions granting FDA authority to require Risk Evaluation and Mitigation Strategies for drugs that raise safety issues